Recently, AGC Biologics held its 2018 Global CMO Consultant Summit from September 10-13, 2018. Most noteworthy, the event brought together leading CMO consultants with AGC management and scientists to discuss timely developments in CMO outsourcing. The Summit consisted of a 3-day symposium in Seattle, WA, and a tour of AGC’s new global headquarters facility in Bothell, Washington. http://www.agcbio.com/global-cmo-consultant-summit-2018.
AGC Biologics, a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH, and CMC Biologics, is a global leader in clinical and commercial manufacturing of therapeutic proteins Outsource / Partner Manufacturing. AGC Biologics offers the highest level of CMO services to its clients from their state-of-the-art facilities in Seattle, WA and Berkeley, CA in the US; Copenhagen, Denmark; Heidelberg, Germany; Chiba, Japan; and Yokohama, Japan. Significantly, the company is growing its global presence with microbial and mammalian capabilities and fulfilling early-phase through late-phase projects at both small and large-scale. Finally, AGC Biologics features a highly-collaborative global team, along with multifaceted experience in a wide range of molecule types, in-house analytical expertise, and an exceptional regulatory track record.